Laboratorio Reig Jofre, S.A. (BME: RJF)

Spain flag Spain · Delayed Price · Currency is EUR
2.590
+0.030 (1.17%)
Dec 19, 2024, 5:35 PM CET
10.68%
Market Cap 205.75M
Revenue (ttm) 333.69M
Net Income (ttm) 9.55M
Shares Out 80.06M
EPS (ttm) 0.12
PE Ratio 21.54
Forward PE 18.36
Dividend 0.04 (1.56%)
Ex-Dividend Date n/a
Volume 47,896
Open 2.550
Previous Close 2.560
Day's Range 2.530 - 2.590
52-Week Range 2.200 - 3.380
Beta 0.92
Analysts n/a
Price Target n/a
Earnings Date Feb 28, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an... [Read more]

Sector Healthcare
Founded 1929
Employees 1,331
Stock Exchange Madrid Stock Exchange
Ticker Symbol RJF
Full Company Profile

Financial Performance

In 2023, Laboratorio Reig Jofre's revenue was 317.95 million, an increase of 15.95% compared to the previous year's 274.21 million. Earnings were 9.41 million, an increase of 16.04%.

Financial Statements

News

There is no news available yet.